L&C Bio jumps 11.76% on Ozempic face treatment plan

The KOSDAQ-listed company is developing a volume-restoring booster from donated human fat, with patents in South Korea, the United States and China ahead of a targeted late-2027 launch.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.